Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heli Tuppurainen

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Duodecim; Laaketieteellinen Aikakauskirja|January 25, 2013
[Restrictions during psychiatric hospitalization]Eila Repo-Tiihonen, Anu Putkonen, Heli Tuppurainen
Psychiatry and Clinical Neurosciences|June 6, 2009
Dopamine D2/3 receptor binding potential and occupancy in midbrain and temporal cortex by haloperidol, olanzapine and clozapineHeli Tuppurainen, Jyrki T Kuikka, Heimo Viinamäki, et al.
Nordic Journal of Psychiatry|July 16, 2010
Extrapyramidal side-effects and dopamine D(2/3) receptor binding in substantia nigraHeli Tuppurainen, Jyrki T Kuikka, Heimo Viinamäki, et al.
European Archives of Psychiatry and Clinical Neuroscience|June 20, 2006
Midbrain dopamine D2/3 receptor binding in schizophreniaHeli Tuppurainen, Jyrki T Kuikka, Mikko P Laakso, et al.
Journal of Psychiatry & Neuroscience : JPN|March 1, 2024
Navigated and individual α-peak-frequency-guided transcranial magnetic stimulation in male patients with treatment-refractory schizophreniaHeli Tuppurainen, Sara Määttä, Mervi Könönen, et al.
Schizophrenia Bulletin|February 21, 2025
Is it Possible To Identify Patients After Their First Hospitalization for a Psychotic Disorder Who Do Not Use Anti-Psychotics and are Not Later Rehospitalized?Amir Krivoy, Jari Tiihonen, Johnatan Nissan, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|January 9, 2025
The time has come for revising the rules of clozapine blood monitoring in Europe. A joint expert statement from the European Clozapine Task ForceHélène Verdoux, Robert A Bittner, Alkomiet Hasan, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Duodecim; Laaketieteellinen Aikakauskirja|January 25, 2013
[Restrictions during psychiatric hospitalization]Eila Repo-Tiihonen, Anu Putkonen, Heli Tuppurainen
Psychiatry and Clinical Neurosciences|June 6, 2009
Dopamine D2/3 receptor binding potential and occupancy in midbrain and temporal cortex by haloperidol, olanzapine and clozapineHeli Tuppurainen, Jyrki T Kuikka, Heimo Viinamäki, et al.
Nordic Journal of Psychiatry|July 16, 2010
Extrapyramidal side-effects and dopamine D(2/3) receptor binding in substantia nigraHeli Tuppurainen, Jyrki T Kuikka, Heimo Viinamäki, et al.
European Archives of Psychiatry and Clinical Neuroscience|June 20, 2006
Midbrain dopamine D2/3 receptor binding in schizophreniaHeli Tuppurainen, Jyrki T Kuikka, Mikko P Laakso, et al.
Journal of Psychiatry & Neuroscience : JPN|March 1, 2024
Navigated and individual α-peak-frequency-guided transcranial magnetic stimulation in male patients with treatment-refractory schizophreniaHeli Tuppurainen, Sara Määttä, Mervi Könönen, et al.
Schizophrenia Bulletin|February 21, 2025
Is it Possible To Identify Patients After Their First Hospitalization for a Psychotic Disorder Who Do Not Use Anti-Psychotics and are Not Later Rehospitalized?Amir Krivoy, Jari Tiihonen, Johnatan Nissan, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|January 9, 2025
The time has come for revising the rules of clozapine blood monitoring in Europe. A joint expert statement from the European Clozapine Task ForceHélène Verdoux, Robert A Bittner, Alkomiet Hasan, et al.
Pageof 1